Orchestra BioMed Announces FDA Breakthrough Device Designation for Virtue Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Cath Lab Digest

Orchestra BioMed Announces FDA Breakthrough Device Designation for Virtue Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease  Cath Lab Digest

First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...